Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-04-12 Purchase |
2022-04-12 4:05 pm |
C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO |
10,000 | $8.4 | $84,000 | 10,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-01-30 Exercise |
2023-02-01 4:09 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO |
12,500 | $0 | 89,506 (Direct) |
View |
| 2023-01-30 Tax Withholding |
2023-02-01 4:09 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO |
4,319 | $7.78 | 89,506 (Direct) |
View |
| 2023-01-30 Exercise |
2023-02-01 4:09 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Schick Kelly Chief People Officer |
3,750 | $0 | 23,847 (Direct) |
View |
| 2023-01-30 Tax Withholding |
2023-02-01 4:09 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Schick Kelly Chief People Officer |
1,301 | $7.78 | 23,847 (Direct) |
View |
| 2023-01-30 Exercise |
2023-02-01 4:09 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer |
3,750 | $0 | 23,847 (Direct) |
View |
| 2023-01-30 Tax Withholding |
2023-02-01 4:09 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer |
1,301 | $7.78 | 23,847 (Direct) |
View |
| 2023-01-30 Exercise |
2023-02-01 4:08 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer |
3,750 | $0 | 95,237 (Direct) |
View |
| 2023-01-30 Tax Withholding |
2023-02-01 4:08 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer |
1,301 | $7.78 | 95,237 (Direct) |
View |
| 2023-01-06 Exercise |
2023-01-06 4:55 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
444 | $4.98 | 300,809 (Direct) |
View |
| 2023-01-06 Exercise |
2023-01-06 4:55 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
268 | $2.11 | 300,809 (Direct) |
View |
| 2023-01-06 Exercise |
2023-01-06 4:55 pm |
N/A 2026-07-12 |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
712 | $0 | 300,809 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 4:17 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
1,568 | $6.38 | 298,140 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 4:17 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | GROGAN DONNA ROY Director |
1,763 | $6.38 | 2,582 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 4:16 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
1,725 | $6.38 | 795,842 (Direct) |
View |
| 2022-10-03 Option Award |
2022-10-04 6:06 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | GROGAN DONNA ROY Director |
819 | $8.69 | 819 (Direct) |
View |
| 2022-10-03 Option Award |
2022-10-04 6:06 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
1,265 | $8.69 | 794,117 (Direct) |
View |
| 2022-10-03 Exercise |
2022-10-04 6:05 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
445 | $4.98 | 299,241 (Direct) |
View |
| 2022-10-03 Exercise |
2022-10-04 6:05 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
267 | $2.11 | 299,241 (Direct) |
View |
| 2022-10-03 Option Award |
2022-10-04 6:05 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
1,150 | $8.69 | 299,241 (Direct) |
View |
| 2022-10-03 Exercise |
2022-10-04 6:05 pm |
N/A 2026-07-12 |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
712 | $0 | 299,241 (Direct) |
View |
| 2022-07-29 Option Award |
2022-08-02 4:24 pm |
N/A 2032-07-28 |
C4 Therapeutics Inc. | CCCC | GROGAN DONNA ROY Director |
41,200 | $0 | 41,200 (Direct) |
View |
| 2022-07-29 Option Award |
2022-08-02 4:23 pm |
N/A 2032-07-28 |
C4 Therapeutics Inc. | CCCC | Bessen Laura Director |
41,200 | $0 | 41,200 (Direct) |
View |
| 2022-07-15 Exercise |
2022-07-18 5:18 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
889 | $4.98 | 298,091 (Direct) |
View |
| 2022-07-15 Exercise |
2022-07-18 5:18 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
535 | $2.11 | 298,091 (Direct) |
View |
| 2022-07-15 Exercise |
2022-07-18 5:18 pm |
N/A 2026-07-12 |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
1,424 | $0 | 298,091 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-05 4:12 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
1,372 | $8.03 | 792,852 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-05 4:11 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
1,246 | $8.03 | 293,286 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-23 4:16 pm |
N/A 2032-06-21 |
C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-23 4:16 pm |
N/A 2032-06-21 |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-23 4:15 pm |
N/A 2032-06-21 |
C4 Therapeutics Inc. | CCCC | COHEN MARC A Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-23 4:15 pm |
N/A 2032-06-21 |
C4 Therapeutics Inc. | CCCC | Salter Malcolm Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-23 4:15 pm |
N/A 2032-06-21 |
C4 Therapeutics Inc. | CCCC | DOWNEY BRUCE Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2022-05-26 Tax Withholding(A) |
2022-06-14 4:45 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer |
1,102 | $7.01 | 2,648 (Direct) |
View |
| 2022-05-26 Tax Withholding(A) |
2022-06-14 4:45 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO |
3,675 | $7.01 | 18,825 (Direct) |
View |
| 2022-05-26 Tax Withholding(A) |
2022-06-14 4:45 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer |
1,102 | $7.01 | 74,038 (Direct) |
View |
| 2022-05-26 Tax Withholding(A) |
2022-06-14 4:45 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | White Lauren Chief Financial Officer |
1,102 | $7.01 | 2,648 (Direct) |
View |
| 2022-05-26 Tax Withholding(A) |
2022-06-14 4:45 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Schick Kelly Chief People Officer |
1,102 | $7.01 | 2,648 (Direct) |
View |
| 2022-05-26 Tax Withholding(A) |
2022-06-14 4:45 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Crystal Adam Chief Medical Officer |
1,102 | $7.01 | 17,648 (Direct) |
View |
| 2022-05-26 Tax Withholding(A) |
2022-06-14 4:45 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
1,102 | $7.01 | 2,648 (Direct) |
View |
| 2022-05-25 Exercise |
2022-05-27 4:16 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer |
3,750 | $0 | 26,250 (Direct) |
View |
| 2022-05-25 Exercise |
2022-05-27 4:16 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Crystal Adam Chief Medical Officer |
3,750 | $0 | 41,250 (Direct) |
View |
| 2022-05-25 Exercise |
2022-05-27 4:16 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Schick Kelly Chief People Officer |
3,750 | $0 | 26,250 (Direct) |
View |
| 2022-05-25 Exercise |
2022-05-27 4:15 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer |
3,750 | $0 | 97,640 (Direct) |
View |
| 2022-05-25 Exercise |
2022-05-27 4:15 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | White Lauren Chief Financial Officer |
3,750 | $0 | 26,250 (Direct) |
View |
| 2022-05-25 Exercise |
2022-05-27 4:15 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer |
3,750 | $0 | 26,250 (Direct) |
View |
| 2022-05-25 Exercise |
2022-05-27 4:15 pm |
N/A 2025-02-28 |
C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO |
12,500 | $0 | 97,500 (Direct) |
View |
| 2022-04-12 Exercise |
2022-04-12 8:41 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer |
25,928 | $4.98 | 155,114 (Direct) |
View |
| 2022-04-12 Exercise |
2022-04-12 8:41 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer |
2,156 | $3.71 | 155,114 (Direct) |
View |
| 2022-04-12 Exercise |
2022-04-12 8:41 pm |
N/A 2028-04-23 |
C4 Therapeutics Inc. | CCCC | Fisher Stewart Chief Scientific Officer |
28,084 | $0 | 155,114 (Direct) |
View |
| 2022-04-04 Option Award |
2022-04-05 4:27 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
379 | $26.46 | 791,480 (Direct) |
View |